عيادة لاستعادة الشعر بإشراف جراح في ليفنت، إسطنبول، منذ 2007.
استعرض الكل ←أرسل 3–5 صور. رد شخصي خلال 24 ساعة — بدون وسطاء.
اطلب الآن ←FUE, DHI or Algorithmic FUE™ — Dr. Arslan recommends based on your photographs and Norwood stage.
احصل على تقييم ← جرّب الحاسبة ←عضو FUE Europe. عيادة معتمدة من وزارة الصحة. ليفنت، إسطنبول — أقل بنسبة 60–80% من بريطانيا أو الولايات المتحدة.
اطّلع على الباقة ←عضو FUE Europe. معتمد من وزارة الصحة. أكثر من 17 عاماً. أكثر من 4500 عملية أجراها بنفسه. مريض واحد في اليوم.
الملف الكامل ←كل طعم يُزرع بيده. وكل نتيجة مسؤوليته الشخصية.
اقرأ الفلسفة ←لا تكاليف خفية. الفندق والمواصلات والعملية والمتابعة في سعر واحد.
اطّلع على الأسعار ←Silver · Gold · VIP — فندق 5 نجوم · مواصلات المطار · PRP مشمول
اطّلع على الأسعار ← حاسبة الطعوم ←ليست كل حالة تحتاج زراعة. علاجات دوائية وعلاجات أخرى وخيارات تخصصية.
نظرة عامة ←Month 2 is the period of maximum patient anxiety — and the period when the least has visibly changed. The shock loss is complete or nearly complete. Transplanted hair has shed. New growth has not yet started. The scalp may look sparser than before the procedure. Patients often contact their clinic convinced the transplant has failed.
This appearance is entirely normal. It is not failure. The follicles are alive beneath the surface — in telogen, the resting phase — recovering from surgical trauma before re-entering anagen. Month 2 is winter. Spring comes at months 3–5.

After surgery, transplanted follicles enter telogen due to the physical and chemical stress of extraction, handling and implantation. The telogen phase typically lasts 8–16 weeks — placing month 2 squarely in the middle of this dormant window. The follicle is intact, alive and cycling. The hair shaft has shed; a new shaft is being prepared for the anagen entry that will occur at months 3–5.
An accurate analogy: a bulb planted in autumn shows no growth in early winter — but the bulb is alive and will emerge in spring. The absence of visible growth at month 2 is biologically identical to this situation.
Normal and expected: No new growth visible. Sparse appearance. Mild residual redness. Some itching as follicles recover.
Contact Hairmedico if: Signs of infection (increasing redness, heat, discharge, fever). Significant folliculitis that does not respond to warm compress. Unusual or increasing pain after the first week.
At Hairmedico, all patients have direct WhatsApp access to the medical team throughout the 12-month follow-up. Any photograph can be submitted for assessment within hours.

Yes. AI is used for trichoscopy donor density mapping, graft count estimation from photographs, and digital hairline design simulation. At Hairmedico, AI-assisted trichoscopy is part of the Algorithmic FUE planning process. Robotic extraction is not used — Dr. Arslan's manual FUE achieves lower transection rates across all hair types.
AI simulation tools can show proposed hairline positions on photographs, but cannot predict actual graft survival (depends on surgeon quality), actual density (depends on hair calibre), or how the result interacts with future native hair loss. They are design communication aids, not result guarantees.
Not in the foreseeable future. AI adds value in data analysis (density mapping, graft counting) but cannot replace the aesthetic judgment required for natural hairline design, the technical adaptation required for diverse hair types, or the long-term clinical planning that accounts for individual hair loss trajectories.
Hairmedico all-inclusive: EUR 1,990–2,900 for 2,000–3,500 grafts including surgery, 5-star hotel, transfers, PRP and 12-month follow-up.
Yes. Transplanted follicles are DHT-resistant and grow permanently for the patient's lifetime.
Desk work: 5–7 days. Scabs shed by Day 10–14. New growth from months 3–5. Final result months 12–14.
Dr. Arslan Musbeh personally — every extraction, every channel, every graft. One patient per day.
Yes, with an accredited surgeon-led clinic. Verify FUE Europe membership, Ministry of Health registration, and confirm the surgeon personally operates.
All references are peer-reviewed medical literature or official health authority publications. No commercial sources included.